enkephalin, leucine has been researched along with oxymorphone in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (65.38) | 18.7374 |
1990's | 6 (23.08) | 18.2507 |
2000's | 2 (7.69) | 29.6817 |
2010's | 1 (3.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Larson, DL; Lemieux, C; Nguyen, TM; Portoghese, PS; Ronsisvalle, G; Schiller, PW; Takemori, AE | 1 |
Lipkowski, AW; Portoghese, PS; Tam, SW | 1 |
Berkowitz, DS; Burt, SK; Loew, GH | 1 |
Costa, EM; Hoffmann, BB; Loew, GH | 1 |
Bykov, V; Holaday, JW; Jacobson, AE; Long, JB; Rice, KC; Rothman, RB | 1 |
Goodman, RR; Hahn, EF; Nishimura, S; Pasternak, GW | 1 |
Hahn, EF; Itzhak, Y; Johnson, N; Nishimura, S; Pasternak, GW | 1 |
Galetta, S; Hahn, EF; Nishimura, S; Pasternak, GW | 1 |
Bodnar, RJ; Burks, TF; Clark, JE; Hahn, EF; Pasternak, GW; Williams, CL | 1 |
Liang, CS; Sakamoto, S | 1 |
Bowen, WD; Herkenham, M; Jacobson, AE; Pert, CB; Rice, KC; Rothman, RB | 1 |
Bowen, WD; Bykov, V; Jacobson, AE; Kooper, GN; Rice, KC; Rothman, RB | 1 |
Giles, TD; Given, MB; Sander, GE | 1 |
Bowen, WD; Burke, TR; Bykov, V; Jacobson, AE; Pert, CB; Rice, KC; Rothman, RB; Schumacher, UK | 1 |
Day, AR; Freer, RJ; Liao, CS | 1 |
Chang, KJ; Cuatrecasas, P; Hazum, E; Leighton, HJ; Lever, OW | 1 |
Giles, T; Merz, H; Sander, G | 1 |
Burke, TR; Danks, JA; Jacobson, AE; Pert, CB; Rice, KC; Rothman, RB | 1 |
Gioannini, TL; Hiller, JM; Itzhak, Y; Simon, EJ | 1 |
Borsodi, A; Búzás, B; Friedmann, T; Fürst, Z; Schmidhammer, H | 1 |
Gao, P | 1 |
DiGiacomo, B; Larson, DL; Ohkawa, S; Portoghese, PS; Takemori, AE | 1 |
Borsodi, A; Hosztafi, S; Nevin, ST; Rónai, AZ; Spetea, M; Tóth, G | 1 |
Salvadori, S; Temussi, PA | 1 |
Virk, MS; Williams, JT | 1 |
Ambrosio, C; Casella, I; Costa, T; Grò, C; Molinari, P; Riitano, D; Sbraccia, M; Vezzi, V | 1 |
2 review(s) available for enkephalin, leucine and oxymorphone
Article | Year |
---|---|
Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Enkephalins; In Vitro Techniques; Methadone; Models, Molecular; Molecular Conformation; Nalorphine; Narcotic Antagonists; Narcotics; Oxymorphone; Piperidines; Quantum Theory; Receptors, Opioid; Structure-Activity Relationship; Thermodynamics | 1978 |
Antagonism in opioid peptides: the role of conformation.
Topics: Animals; Binding Sites; Drug Design; Enkephalin, Leucine; Humans; Morphine Derivatives; Narcotic Antagonists; Opioid Peptides; Oxymorphone; Peptides, Cyclic; Protein Conformation; Protein Structure, Tertiary; Receptors, Opioid; Receptors, Opioid, delta; Spiro Compounds; Structure-Activity Relationship | 2004 |
24 other study(ies) available for enkephalin, leucine and oxymorphone
Article | Year |
---|---|
Hybrid bivalent ligands with opiate and enkephalin pharmacophores.
Topics: Analgesics; Animals; Enkephalins; Guinea Pigs; Hydromorphone; Ligands; Male; Mice; Muscle, Smooth; Naloxone; Oxymorphone; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu | 1987 |
Peptides as receptor selectivity modulators of opiate pharmacophores.
Topics: Animals; Dynorphins; Endorphins; Enkephalin, Leucine; Guinea Pigs; Indicators and Reagents; Kinetics; Oligopeptides; Receptors, Opioid; Structure-Activity Relationship | 1986 |
Opioid agonists binding and responses in SH-SY5Y cells.
Topics: Alprostadil; Analgesics; Cyclic AMP; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fentanyl; GTP Phosphohydrolases; Humans; Meperidine; Morphinans; Naloxone; Narcotics; Oxymorphone; Receptors, Opioid; Receptors, Opioid, mu; Tumor Cells, Cultured | 1992 |
Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors.
Topics: Animals; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; In Vitro Techniques; Isothiocyanates; Kinetics; Naltrexone; Narcotic Antagonists; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Thiocyanates; Up-Regulation | 1990 |
Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
Topics: Animals; Binding, Competitive; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Hydromorphone; In Vitro Techniques; Male; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Structure-Activity Relationship | 1985 |
Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
Topics: Albumins; Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Hydrazones; Hydromorphone; In Vitro Techniques; Male; Naloxone; Narcotic Antagonists; Narcotics; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Structure-Activity Relationship; Tritium | 1985 |
Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.
Topics: Analgesia; Animals; Binding, Competitive; Brain; Dihydromorphine; Endorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Hydromorphone; Male; Mice; Mice, Inbred ICR; Naltrexone; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Sodium | 1987 |
Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Hydrazones; Hydromorphone; Male; Mice; Naloxone; Oxymorphone; Receptors, Opioid; Time Factors | 1988 |
Opiate receptor inhibition improves the blunted baroreflex function in conscious dogs with right-sided congestive heart failure.
Topics: Animals; Blood Pressure; Consciousness; Dogs; Electrocardiography; Enkephalin, Leucine; Heart Failure; Naloxone; Narcotic Antagonists; Oxymorphone; Phenylephrine; Pressoreceptors; Receptors, Opioid; Reflex | 1989 |
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
Topics: Animals; Autoradiography; Brain; Chlorides; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Guanosine Triphosphate; Hydromorphone; Male; Manganese; Manganese Compounds; Mathematics; Membranes; Oligopeptides; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Sodium Chloride | 1985 |
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone ([3H]FOXY): a new ligand and photoaffinity probe for the mu opioid receptors.
Topics: Affinity Labels; Animals; Brain; Chlorides; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; In Vitro Techniques; Male; Manganese; Manganese Compounds; Membranes; Oxymorphone; Photochemistry; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Tritium | 1988 |
Non-opiate and peripheral-opiate cardiovascular effects of morphine in conscious dogs.
Topics: Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Dogs; Enkephalin, Leucine; Female; Heart Rate; Kinetics; Male; Morphine; Naloxone; Oxymorphone | 1986 |
Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric model.
Topics: Alkylating Agents; Allosteric Regulation; Animals; Brain; Cell Membrane; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fentanyl; Isothiocyanates; Kinetics; Male; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Thiocyanates | 1984 |
Evidence for a single opioid receptor type on the field stimulated rat vas deferens.
Topics: Animals; Benzimidazoles; beta-Endorphin; Dose-Response Relationship, Drug; Electric Stimulation; Endorphins; Enkephalins; Etorphine; Fentanyl; Male; Morphine; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Sufentanil; Vas Deferens | 1981 |
Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking.
Topics: Animals; Binding, Competitive; Biological Assay; Brain; Cell Membrane; Chemical Phenomena; Chemistry; Endorphins; Enkephalins; Guinea Pigs; Hydromorphone; Ileum; Kinetics; Muscle Contraction; Oxymorphone; Receptors, Opioid; Structure-Activity Relationship | 1982 |
Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
Topics: Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Enkephalin, Leucine; Heart Rate; Hydromorphone; Naloxone; Naltrexone; Oxymorphone; Quaternary Ammonium Compounds | 1983 |
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific binding.
Topics: Animals; Benzomorphans; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Fentanyl; Hydromorphone; Isothiocyanates; Kinetics; Oxymorphone; Rats; Receptors, Opioid; Receptors, Opioid, mu; Thiocyanates; Tomography, Emission-Computed | 1984 |
Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites.
Topics: Animals; Brain; Bufo marinus; Digitonin; Diprenorphine; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Etorphine; Male; Naloxone; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Species Specificity | 1984 |
Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.
Topics: Analgesics; Animals; Behavior, Animal; Binding Sites; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Guinea Pigs; Male; Mice; Morphine Derivatives; Naloxone; Oxymorphone; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Species Specificity; Substance-Related Disorders | 1993 |
Comparison of cyclic delta-opioid peptides with non-peptide delta-agonist spiroindanyloxymorphone (SIOM) using the message-address concept: a molecular modeling study.
Topics: Drug Design; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Naltrexone; Narcotic Antagonists; Oxymorphone; Peptides, Cyclic; Protein Binding; Protein Conformation; Receptors, Opioid, delta; Spiro Compounds; Structure-Activity Relationship | 1996 |
7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors.
Topics: Analgesia; Analgesics; Animals; Brain; Cell Membrane; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Guinea Pigs; Ileum; Ligands; Male; Mice; Mice, Inbred ICR; Molecular Structure; Muscle, Smooth; Naltrexone; Oxymorphone; Receptors, Opioid, delta; Spiro Compounds; Vas Deferens | 1997 |
Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids.
Topics: Animals; Benzeneacetamides; Benzofurans; Binding, Competitive; Brain; Cell Membrane; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Naloxone; Naltrexone; Oligopeptides; Oxycodone; Oxymorphone; Pyrrolidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Tritium | 1998 |
Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization.
Topics: Analgesics, Opioid; Animals; Down-Regulation; Electrophysiology; Enkephalins; Etorphine; Fentanyl; In Vitro Techniques; Male; Naltrexone; Oxymorphone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2008 |
Morphine-like opiates selectively antagonize receptor-arrestin interactions.
Topics: Arrestins; beta-Arrestin 2; beta-Arrestins; Cell Line, Tumor; Cell Membrane; Enkephalins; GTP-Binding Protein alpha Subunits; Humans; Narcotics; Oxymorphone; Pertussis Toxin; Receptors, Opioid, delta; Receptors, Opioid, mu | 2010 |